Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics

• Status: Completed
• Trial end date: 2014-01-10
• Target enrollment: 0
• Participant gender: All

Summary

This study will determine whether combination treatment driven by patient choice is better than standardized medication treatment at retaining and improving Hispanic patients with major depressive disorder.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: New York State Psychiatric Institute
• Collaborator: National Institute of Mental Health (NIMH)
• Treatments: Antidepressive Agents; Bupropion

Criteria

Inclusion Criteria:

• Hispanic males and females

• DSM-IV criteria for non-psychotic major depressive disorder (MDD) of at least moderate severity (HAM-D-17> 18)

• 18- 79

• Patients with stable dosage of Benzodiazepines to treat anxiety disorders

Exclusion Criteria:

• At risk of attempting suicide

• Unstable medical illness

• History of bipolar disorder, schizophrenia, or other psychotic disorder

• Pregnant or lactating

• Alcohol or substance use disorder that requires acute detoxification